Gilead rose 1.4% after hours on October 29 after quarterly earnings beat forecasts and its product-sales outlook increased. A deeper annual loss forecast adds a caution to the stronger sales picture.
Read the full research in the app
A subscription is required to access the full thread.
Open in the app →Financials
Technicals